Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
Saved in:
| Title: | Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis. |
|---|---|
| Authors: | Koether K; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Besnard V; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France., Sandig H; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Carruthers A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Miranda E; Imaging and AI, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Grootenboer-Mignot S; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Taillé C; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France., Chevret S; Biostatistics and Clinical Epidemiology team, INSERM UMR 1153, Université de Paris, SBIM- Hôpital Saint Louis, Paris, France., Valeyre D; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Nunes H; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Israel-Biet D; AP-HP, Hôpital Européen Georges Pompidou, Service de Pneumologie, Université de Paris, Paris, France., Lim WK; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Cottin V; Hospices Civils de Lyon, Hôpital Louis Pradel, Université Claude Bernard Lyon 1, Lyon, France., Corkill D; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dobson C; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Groves M; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Ferraro F; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Guenzi E; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Département d'Anatomopathologie, Paris, France., Huang L; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sulikowski M; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mailleux A; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Murray LA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mustelin T; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA., Strickland I; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Sleeman MA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Crestani B; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France bruno.crestani@aphp.fr.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript. |
| Source: | The European respiratory journal [Eur Respir J] 2023 May 18; Vol. 61 (5). Date of Electronic Publication: 2023 May 18 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
